Inovio Pharmaceuticals, Inc. (INO): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2024-03-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

69.00M
As of 2025-12-31
82.34M
As of 2026-06-30
+48.4%
3-year compound annual growth
217.38M2010-12-31: 105.04M2011-12-31: 134.97M2012-12-31: 144.31M2013-12-31: 52.58M2014-12-31: 60.74M2015-12-31: 72.22M2016-12-31: 74.06M2017-12-31: 90.36M2018-12-31: 97.23M2019-12-31: 101.36M2020-12-31: 186.85M2021-12-31: 217.38M2022-12-31: 21.09M2023-12-31: 22.79M2024-12-31: 36.10M2025-12-31: 69.00M69.00M
2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3169.00M+91.1%2026-03-12, Balance as of period end
2024-12-3136.10M+58.4%2026-03-12, Balance as of period end
2023-12-3122.79M+8.1%2025-03-18, Balance as of period end
2022-12-3121.09Mn/c2024-03-06, Balance as of period end
2021-12-31217.38M+16.3%2023-03-01, Balance as of period end
2020-12-31186.85M+84.3%2022-03-01, Balance as of period end
2019-12-31101.36M+4.3%2021-03-01, Balance as of period end
2018-12-3197.23M+7.6%2020-03-12, Balance as of period end
2017-12-3190.36M+22.0%2019-03-12, Balance as of period end
2016-12-3174.06M+2.6%2018-03-14, Balance as of period end
2015-12-3172.22M+18.9%2017-03-15, Balance as of period end
2014-12-3160.74M+15.5%2016-03-14, Balance as of period end
2013-12-3152.58M-63.6%2015-03-16, Balance as of period end
2012-12-31144.31M+6.9%2014-03-17, Balance as of period end
2011-12-31134.97M+28.5%2013-03-18, Balance as of period end
2010-12-31105.04Mn/a2012-03-15, Balance as of period end